KC-2519

HEK293-LILRB2-isoform2 Cell Line

×
Please enable JavaScript in your browser to complete this form.
24224
Home » HEK293-LILRB2-isoform2 Cell Line

Background of HEK293-LILRB2-isoform2 Cell Line

LILRB2, also named as ILT4, CD85d, is member of the leukocyte immunoglobulin-like (LIR) family, and primarily expressed on monocytes, dendritic cells and neutrophils. Recent studies show LILRB2 can potentially act as a myeloid immune checkpoint by reprogramming tumor- associated myeloid cells and provoking antitumor immunity. LILRB2 has multiple alternatively spliced isoforms. Isoform 2 is one of the clearly defined protein-coding variants, which has been successfully expressed as a functional membrane protein and is used for drug screening and biological assays.

Specifications

Catalog NumberKC-2519
Cell Line NameHEK293-LILRB2-isoform2 Cell Line
NCBI/UniProt Accession NumberNM_001080978.4
Clone Number2#
Host Cell LineHEK293
DescriptionStable HEK293 clone expressing exogenous LILRB2 gene isoform 2
QuantityTwo vials of frozen cells (≥2-106/vial)
StabilityStable in culture over a minimum of 10 passages
ApplicationDrug screening and biological assays
Freezing Medium70% DMEM + 20% FBS + 10% DMSO
Propagation MediumDMEM + 10% FBS + 1μg/mL Puromycin
Selection MarkerPuromycin
MorphologyEpithelial
SubcultureSplit saturated culture 1:4-1:5 every 2-3 days; seed out at about 1-3 × 105 cells/mL
Incubation37 °C with 5% CO2
StorageLiquid nitrogen immediately upon receiving
Doubling TimeApproximately 30 hours
Mycoplasma StatusNegative
In Vivo ValidationNA

Cell Line Generation

HEK293-LILRB2-isoform2 cell line was generated using a lentiviral vector expressing the LILRB2 gene isoform 2 sequence.

Characterization

Figure: Characterization of LILRB2 overexpression in the HEK293-LILRB2-isoform2 stable clone using FACS.

Cell Resuscitation

1. Prewarm culture medium (DMEM + 10% FBS + 1μg/mL Puromycin)in a 37°C water bath.
2. Thaw the frozen vial in a 37°C water bath for 1-2 minutes.
3. Transfer the vial into biosafety cabinet, and wipe the surface with 70% ethanol.
4. Unscrew the top of the vial and transfer the cell suspension gently into a sterile centrifuge tube containing 9.0mL complete culture medium.
5. Spin at ~ 125 × g for 5-7 minutes at room temperature, and discard the supernatant without disturbing the pellet.
6. Resuspend cell pellet with the appropriate volume of complete medium and transfer the cell suspension into a T25 culture flask.
7. Incubate the flask at 37°C, 5% CO2 incubator.
8. Split saturated culture 1:4-1:5 every 2-3 days; seed out at about 1-3 × 105 cells/mL.

Cell Freezing

1. Prepare the freezing medium (70% DMEM + 20% FBS + 10% DMSO) fresh immediately before use.
2. Keep the freezing medium on ice and label cryovials.
3. Transfer cells to a sterile, conical centrifuge tube, and count the cells.
4. Centrifuge the cells at 250×g for 5 minutes at room temperature and carefully aspirate off the medium.
5. Resuspend the cells at a density of at least 3×106 cells/mL in chilled freezing medium.
6. Aliquot 1 mL of the cell suspension into each cryovial.
7. Freeze cells in the CoolCell freezing container overnight in a -80°C freezer.
8. Transfer vials to liquid nitrogen for long-term storage.

References

1. Cella M, Dohring C, Samaridis J, Dessing M, Brockhaus M, Lanzavecchia A, Colonna M (June 1997). A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J Exp Med. 185 (10): 1743–51. doi:10.1084/jem.185.10.1743.
2. Samaridis J, Colonna M (April 1997). Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways. Eur J Immunol. 27 (3): 660–5. doi:10.1002/eji.1830270313.
3. Fanger, N A; Cosman D; Peterson L; Braddy S C; Maliszewski C R; Borges L (November 1998). The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes. Eur. J. Immunol. 28 (11): 3423–34.
Please enable JavaScript in your browser to complete this form.